摘要
CRISPR/Cas系统可以进行基因敲入、敲除、单碱基突变和表观遗传调控,在生物医学领域有广阔的发展前景,为探索疾病发生和发展的机制、发现药物靶点提供了新思路。该文对CRISPR/Cas系统、Cas9的功能和在肿瘤中的应用,包括模型构建、机制研究、分子诊断、生物治疗和药物研发与筛选方面进行了概述,同时讨论了CRISPR/Cas9在肿瘤基础研究和临床治疗中的不足,并展望其应用前景。
The recent developed CRISPR/Cas system can be used in gene knock-in,knock-out,single base mutation and epigenetic regulation.Technologies based on CRISPR/Cas have a wide developmental prospect in biomedicine.It puts forward new ways for exploring the mechanism of disease development,uncovering high-confidence biomarkers and screening target drugs.This paper focused on the revolutionary CRISPR/Cas system and the application of CRISPR/Cas9 in cancer,including model construction,mechanism research,molecular diagnosis,biotherapy,drug development and screening.The limitations and prospects of CRISPR/Cas9 in cancer research and clinical therapy were also discussed.
作者
马孟丹
杨育宾
陈延萍
吴果
刘宇辰
黄卫人
MA Meng-Dan;YANG Yu-Bin;CHEN Yan-Ping;WU Guo;LIU Yu-Chen;HUANG Wei-Ren(Shenzhen Institute of Synthetic Biology,Institute of Translational Medicine,Shenzhen Second Hospital,Shenzhen 518036,China;Shantou University Medical College,Shantou 515041,China)
出处
《生命科学》
CSCD
北大核心
2021年第11期1370-1381,共12页
Chinese Bulletin of Life Sciences
基金
国家重点研发计划(2019YFA0906000)
国家自然科学基金项目(81772737,81772736,81972867)。